Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × danusertib × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Genitourinary 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 266 Bortezomib 148 Lenalidomide 116 pomalidomide 90 daratumumab 83 carfilzomib 59 Cyclophosphamide 41 Calcium Dobesilate 33 belantamab mafodotin 28 fludarabine 26 elotuzumab 24 Melphalan 21 ixazomib 20 isatuximab 20 venetoclax 15 selinexor 15 Prednisone 15 talquetamab 13 Panobinostat 13 plerixafor 11 Granulocyte Colony-Stimulating Factor 11 idecabtagene vicleucel 10 Zoledronic Acid 10 Thalidomide 10 Injections 10 pembrolizumab 9 nirogacestat 9 Methylprednisolone 9 Azacitidine 9 iberdomide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00872300 2014-05-28

PHA-739358 for the Treatment of Multiple Myeloma

Nerviano Medical Sciences

Phase 2 Terminated

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡